- Tags: dry eye
Pipeline
Palatin reports symptom resolution phase 3 data for DED eye drop
Responder analyses indicate PL9643 achieved statistically significant complete symptom clearing across multiple endpoints starting at 2 weeks and increasing to week 12.
Pipeline
Long-term data finds acoltremon 0.003% increases tear production in DED
Presented at ASCRS, phase 3 COMET-4 results show AR-15512 provides a rapid onset and sustained improvement over 12 months.
Business
CSI Dry Eye Software selects new CEO
Eye care industry executive Ken Barbet takes the helm as the AI-based dry eye management platform seeks to help ECPs standardize and deliver customized treatment.
Products
TearRestore launches eyelid serum for digital eye strain
Available over the counter, the WINQ Eyelid Serum is clinically studied and supported in reducing partial blink rates by 50% after just one application.
Research
Do personality traits play a role in DED development?
New study links higher neuroticism, lower conscientiousness to increased odds of dry eye disease.
Pipeline
FDA rejects Aldeyra's reproxalap NDA for a second time
Agency states the candidate failed to demonstrate efficacy in treating ocular symptoms associated with dry eyes; company plans for a third submission.
Business
Eyenovia proposes merger with Betaliq to form glaucoma company
Potential deal would result in a new glaucoma-focused company combining the EyeSol water-free drug delivery tech and Optejet device platform.
Events
Eyes On Dry Eye spotlights next-gen treatments and hot topics
The largest dry eye event of the year features over 12,000 hours of continuing education.
Pipeline
Phase 4 data presents early patient-reported outcomes of MIEBO
Study finds symptom relief achieved as early as 5 to 60 minutes on day 1 of dosing—with significant reduction in overall severity after 14 days.
Products
Harrow launches VEVYE accessibility program for patients
VEVYE Access for All initiative eliminates prior authorization submission delays, expedites prescription deliveries, and lowers prescription costs for qualifying patients.
Research
How effective are autologous serum tears for Sjögren's syndrome at 50% concentration?
Serum tears showed improvements in DED signs and corneal nerve regeneration.
Products
Patient studies show iVIZIA lubricant eye drops provide relief for all forms of dry eye
Real-world research reveals that patients experience immediate relief lasting up to 8 hours with iVIZIA Lubricant Eye Drops.
Products
Blinkjoy launches rechargeable heat mask for dry eyes
With advanced heating technology, the mask is designed to increase tear film stability, treat styes, and support a healthy eyelid margin.
Products
Alcon launches Systane Pro PF drops for dry eye
Over-the-counter artificial tear is marketed as the “longest lasting eye drop” in the company’s SYSTANE portfolio.
Products
Lumenis launches OptiLIFT to address lower lid laxity and impaired blinking
Medical device features a new dynamic muscle stimulation technology that tightens and tones the periorbital area via a noninvasive, surgery-free procedure.Events
Registration opens for Eyes On Dry Eye 2025
The largest virtual dry eye event of the year offers up to 7 hours of free CE from leading clinical experts in the industry.
Research
Is there a link between peripheral neuropathy and DED risk?
Study finds association between diabetic peripheral neuropathy and risk of developing DED.
Events
Dry Eye Institute launches on-demand and hybrid educational programs
In-person, two-day event kicks off at the end of January while new comprehensive training and resources are available for ECPs to learn on the go.
Products
Alcon voluntarily recalls Systane Lubricant Eye Drops Ultra PF
Late last month, the FDA reported a potential risk for fungal contamination associated with one lot of the preservative-free eye drops.
Pipeline